Table 3 Pre-intervention (year 2003) and post-intervention (year 2004) values of primary outcomes, their individual components (in brackets) and change over time for each of the 3 arms
Primary outcomes (Individual components) | Arm | Pre-intervention value % | Post-intervention value % | Δ% |
|---|---|---|---|---|
Metabolic control | Active implementation | 11,0 (218/1973) | 11,9 (235/1973) | 7,8 |
Passive dissemination | 7,7 (169/2190) | 10,1 (222/2190) | 31,4 | |
Usual care | 8,8 (196/2232) | 10,3 (230/2232) | 17,3 | |
Macrovascular complications | Active implementation | 12,7 (250/1973) | 14,0 (277/1973) | 10,8 |
Passive dissemination | 10,7 (235/2190) | 11,7 (257/2190) | 9,4 | |
Usual care | 10,9 (244/2232) | 12,4 (277/2232) | 13,5 | |
(ECG) | Active implementation | 26,1 (515/1973) | 26,0 (513/1973) | -0,4 |
Passive dissemination | 25,9 (568/2190) | 25,0 (547/2190) | -3,7 | |
Usual care | 24,9 (555/2232) | 24,2 (541/2232) | -2,5 | |
(Lipid profile) | Active implementation | 30,8 (608/1973) | 35,7 (705/1973) | 16,0 |
Passive dissemination | 25,7 (563/2190) | 28,5 (624/2190) | 10,8 | |
Usual care | 25,0 (559/2232) | 30,3 (677/2232) | 21,1 | |
Microvascular complications | Active implementation | 5,3 (104/1973) | 6,9 (136/1973) | 30,8 |
Passive dissemination | 4,5 (98/2190) | 4,9 (108/2190) | 10,2 | |
Usual care | 5,0 (112/2232) | 4,7 (105/2232) | -6,3 | |
(Retinal screening) | Active implementation | 25,0 (494/1973) | 26,6 (525/1973) | 6,3 |
Passive dissemination | 24,2 (530/2190) | 23,9 (523/2190) | -1,3 | |
Usual care | 22,9 (512/2232) | 22,7 (507/2232) | -1,0 | |
(Microalbuminuria) | Active implementation | 10,5 (208/1973) | 13,7 (271/1973) | 30,3 |
Passive dissemination | 8,7 (191/2190) | 10,5 (229/2190) | 19,9 | |
Usual care | 9,8 (219/2232) | 11,9 (265/2232) | 21,0 | |
(Creatinine serum level) | Active implementation | 54,6 (1078/1973) | 54,2 (1070/1973) | -0,7 |
Passive dissemination | 48,7 (1067/2190) | 51,6 (1129/2190) | 5,8 | |
Usual care | 47,1 (1052/2232) | 50,4 (1124/2232) | 6,8 |